<p>Vaccination boosts the natural immunity in people infected with the novel coronavirus so much that they are likely protected even from the emerging variants, according to a study.</p>.<p>Researchers at the Rockefeller University in the US analysed antibodies present in the blood of Covid patients, tracking the evolution of these molecules.</p>.<p>The 63 people in the study, which has not been peer-reviewed yet, had Covid in the spring of last year.</p>.<p>Data from their follow-ups show that, over time, antibodies produced by the immune system's memory B cells got better at neutralising SARS-CoV-2, the virus that causes Covid-19.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/opinion/the-world-should-learn-from-india-s-covid-19-cataclysm-992353.html" target="_blank">The world should learn from India’s Covid-19 cataclysm</a></strong></p>.<p>The memory B cells serve as an immune reservoir that contains a diverse collection of antibodies.</p>.<p>The study suggests that these people were developing an improved, long lasting defence against the virus.</p>.<p>The researchers found that these antibodies were further enhanced among 26 people in the group who had received at least one dose of the Moderna or Pfizer vaccine.</p>.<p>This subset of people developed antibodies that are exceptionally resistant to the most concerning SARS-CoV-2 variants, such as those first isolated in the UK, South Africa, and New York City in the US.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/international/world-news-politics/new-york-s-excelsior-pass-is-the-first-covid-19-vaccine-passport-in-us-992354.html" target="_blank">New York’s ‘Excelsior Pass’ is the first Covid-19 vaccine passport in US</a></strong></p>.<p>According to the researchers, these potent antibodies are produced by groups of highly evolved memory B cells, which expand dramatically after a nudge by the vaccines.</p>.<p>The study also suggests that well-timed boosters with the current vaccines may provide additional protection in people who have never had the disease. </p>
<p>Vaccination boosts the natural immunity in people infected with the novel coronavirus so much that they are likely protected even from the emerging variants, according to a study.</p>.<p>Researchers at the Rockefeller University in the US analysed antibodies present in the blood of Covid patients, tracking the evolution of these molecules.</p>.<p>The 63 people in the study, which has not been peer-reviewed yet, had Covid in the spring of last year.</p>.<p>Data from their follow-ups show that, over time, antibodies produced by the immune system's memory B cells got better at neutralising SARS-CoV-2, the virus that causes Covid-19.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/opinion/the-world-should-learn-from-india-s-covid-19-cataclysm-992353.html" target="_blank">The world should learn from India’s Covid-19 cataclysm</a></strong></p>.<p>The memory B cells serve as an immune reservoir that contains a diverse collection of antibodies.</p>.<p>The study suggests that these people were developing an improved, long lasting defence against the virus.</p>.<p>The researchers found that these antibodies were further enhanced among 26 people in the group who had received at least one dose of the Moderna or Pfizer vaccine.</p>.<p>This subset of people developed antibodies that are exceptionally resistant to the most concerning SARS-CoV-2 variants, such as those first isolated in the UK, South Africa, and New York City in the US.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/international/world-news-politics/new-york-s-excelsior-pass-is-the-first-covid-19-vaccine-passport-in-us-992354.html" target="_blank">New York’s ‘Excelsior Pass’ is the first Covid-19 vaccine passport in US</a></strong></p>.<p>According to the researchers, these potent antibodies are produced by groups of highly evolved memory B cells, which expand dramatically after a nudge by the vaccines.</p>.<p>The study also suggests that well-timed boosters with the current vaccines may provide additional protection in people who have never had the disease. </p>